{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:21:00Z","timestamp":1758979260435},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.3816\/clm.2009.n.079","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T21:03:10Z","timestamp":1256590990000},"page":"E21-E24","source":"Crossref","is-referenced-by-count":8,"title":["Low-Dose Gemcitabine Efficacious in Three Patients With Tumor-Stage Mycosis Fungoides"],"prefix":"10.3816","volume":"9","author":[{"given":"Timo","family":"Buhl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans P.","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell M.","family":"Kaune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Mitteldorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Kretschmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2009.n.079_bib1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2009.n.079_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.n.079_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2009.n.079_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2009.n.079_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and Sezary syndrome","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"key":"10.3816\/CLM.2009.n.079_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2007.12.021","article-title":"Stem cell transplantation in advanced cutaneous T-cell lymphoma","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2009.n.079_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-121-8-199410150-00007","article-title":"Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome)","volume":"121","author":"Bunn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2009.n.079_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.144.6.727","article-title":"Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sezary syndrome","volume":"144","author":"Quereux","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2009.n.079_bib9","article-title":"Preclinical, pharmacologic, and phase I studies of gemcitabine","volume":"24","author":"Storniolo","year":"1997","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2009.n.079_bib10","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1200\/JCO.2000.18.13.2615","article-title":"Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study","volume":"18","author":"Santoro","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.079_bib11","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1200\/JCO.1999.17.12.3786","article-title":"Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma","volume":"17","author":"Fossa","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.079_bib12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2000.18.13.2603","article-title":"Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients","volume":"18","author":"Zinzani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.079_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CLM.2006.n.039","article-title":"Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma","volume":"7","author":"Duvic","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLM.2009.n.079_bib14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1445-5994.1999.tb00795.x","article-title":"Gemcitabine and the blood brain barrier","volume":"29","author":"Davis","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.3816\/CLM.2009.n.079_bib15","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/cncr.21449","article-title":"Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients","volume":"104","author":"Marchi","year":"2005","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.n.079_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1016214032272","article-title":"A report on serious pulmonary toxicity associated with gemcitabine-based therapy","volume":"20","author":"Roychowdhury","year":"2002","journal-title":"Invest New Drugs"},{"key":"10.3816\/CLM.2009.n.079_bib17","first-page":"708","article-title":"Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer","volume":"9","author":"Shaib","year":"2008","journal-title":"JOP"},{"key":"10.3816\/CLM.2009.n.079_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","article-title":"A phase I clinical, plasma, and cellular pharmacology study of gemcitabine","volume":"9","author":"Abbruzzese","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.079_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00535-005-1724-7","article-title":"Comparison of standard-dose and lowdose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial","volume":"41","author":"Sakamoto","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.3816\/CLM.2009.n.079_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000121002","article-title":"Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine","volume":"73","author":"Awar","year":"2007","journal-title":"Oncology"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011700282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011700282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T15:29:10Z","timestamp":1544887750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011700282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1557919011700282"],"URL":"https:\/\/doi.org\/10.3816\/clm.2009.n.079","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}